NATCO Pharma stock | 2026 trend & analyst price target

NATCO Pharma

NSEI:NATCOPHARM

Rp 973,70

Rp0,00 (0,00%)

973,70 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

NATCO Pharma Stock Value

Analysts currently give NSEI:NATCOPHARM a rating of Hold.

Hold

NATCO Pharma Company Info

EPS Growth 5Y

33,04%

Market Cap

Rp174,40 B

Long-Term Debt

Rp0,97 B

Annual earnings

05/27/2026 (E)

Dividend

Rp4,97

Dividend Yield

0,51%

Founded

1981

Industry

Health Care

Country

India

Website

NATCO Pharma

ISIN Number

INE987B01026

Website

http://www.natcopharma.co.in

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp974,00

0.03%

Last Update: 03/28/2026

Analysts: 11

Highest Price Target Rp1.480,00

Average Price Target Rp974,00

Lowest Price Target Rp712,00

In the last five quarters, NATCO Pharma’s Price Target has fallen from Rp1.068,95 to Rp822,45 - a -23,06% decrease. Nine analysts predict that NATCO Pharma’s share price will increase in the coming year, reaching Rp974,00. This would represent an increase of 0,03%.

Top growth stocks in the health care sector (5Y.)

What does NATCO Pharma do?

NATCO Pharma Limited a pharmaceutical company that engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates. Business Segments The company operates through Generic Pharmaceuticals, Branded Formulations, Active Pharmaceutical Ingredients (API), and International Business segments. Generic Pharmaceuticals This segment focuses on the production of affordable generics that replicate the effectiveness of b...

Business Segments

The company operates through Generic Pharmaceuticals, Branded Formulations, Active Pharmaceutical Ingredients (API), and International Business segments.

Generic Pharmaceuticals

This segment focuses on the production of affordable generics that replicate the effectiveness of brand-name drugs. This segment has carved a niche in specialized generics, particularly in complex therapeutic areas, such as oncology. The company continually develops new formulations to enhance patient compliance and efficacy.

Branded Formulations

This segment is active in developing branded prescription medications that cater to specific therapeutic needs. This segment is characterized by innovative research and product differentiation that meets the demands of physicians and patients alike.

Active Pharmaceutical Ingredients (API)

This segment specializes in the development and production of APIs, which are the core components of pharmaceutical products. This segment underscores the company's commitment to maintaining robust supply chains and control over product quality.

International Business

This segment actively markets its products in various international markets, emphasizing compliance with diverse regulatory requirements. By expanding its geographical reach, this segment seeks to capitalize on global opportunities and bolster its position in the international pharmaceutical arena.

Business Strategy

The company's business strategy hinges on a multi-faceted approach aimed at consolidating its position as a robust player in the pharmaceutical industry. strategic direction involves leveraging its innovative capabilities while focusing on sustainability and operational excellence.

Products and Services

The company offers an extensive range of products and services designed to cater to varying healthcare needs. The product portfolio largely includes:

Generic Medicines: The company's generic formulations span multiple therapeutic areas, including oncology, cardiology, and anti-infectives. The company focuses on developing high-quality generics that ensure affordability without compromising on efficacy.

Branded Products: The company is known for its proprietary branded medications that are often positioned as vital treatment options in the market. These products undergo rigorous research and development to differentiate them from generics and to maintain competitive advantages.

Active Pharmaceutical Ingredients (APIs): The company manufactures a diverse range of APIs that serve as fundamental components in various medications. This segment underpins the company’s commitment to quality and regulatory compliance.

Contract Manufacturing: The company offers contract manufacturing services for various pharmaceutical products. This service is beneficial for other pharmaceutical companies looking for reliable production partners.

Research and Development Services: The company is dedicated to advancing drug formulations, delivery mechanisms, and therapeutic innovations. The company often partners with other pharmaceutical entities to develop complex therapies and improve existing formulations.

Patient Assistance Programs: The company is committed to social responsibility and healthcare access, offering patient assistance programs that provide medications at reduced costs for underserved populations.

Geographical Markets

The company operates not only in the domestic market of India, but also in numerous international regions. The company’s geographical markets include.

India: The company primary market, where it enjoys a significant market share in various therapeutic areas.

The United States: The company has established a presence in this lucrative market, focusing on both generic and branded products.

Europe: The company extends its reach to various European countries, aligning with strict regulatory standards.

Africa and the Middle East: The company actively markets its products across these regions, catering to local healthcare needs.

The Asia-Pacific: The company is expanding its footprint in this rapidly growing market by tapping into emerging economies and healthcare systems.

Customers Names

The company serves a diverse customer base that includes.

Healthcare Providers: The company’s Hospitals, clinics, and healthcare professionals constitute a significant portion of the customer base. These customers rely on company for effective medications and reliable supply chains to meet patient needs.

Pharmacies: The company’s retail and wholesale pharmacies across various geographical markets contribute to the distribution of products.

Government Entities: The company engages with governmental health agencies to supply medications for public health initiatives, particularly for the treatment of prevalent diseases.

International Distributors: The company partners with international distributors to enhance its product reach globally, serving customers in multiple countries.

Sales and Marketing

The company employs a multifaceted approach to sales and marketing, focusing on building strong relationships with stakeholders across the healthcare spectrum.

Direct Marketing: The company engages healthcare professionals and institutions directly. This involves presenting new products, educating on usage, and offering samples.

Digital Platforms: The company utilizes digital marketing strategies to reach broader audiences. Online platforms, social media, and professional networks are essential components of its outreach.

Retail Partnerships: The company collaborates with pharmacies and healthcare distributors to ensure robust market penetration. This involves creating promotional campaigns that highlight the benefits of products.

Exhibitions and Conferences: Exhibitions and conferences are a key marketing strategy. These events allow to highlight its innovations and foster connections with healthcare providers.

Patient Education: The company emphasizes patient education through information sessions, brochures, and educational materials. By educating patients about its products, the company enhances brand loyalty and adherence.

Government Regulations

The company is committed to adhering to all applicable government regulations and environmental laws governing its operations. The company ensures compliance with

Pharmaceutical Regulations: The company adheres to regulations set forth by domestic and international pharmaceutical agencies, which govern product development, testing, manufacturing, and marketing. This includes following the guidelines provided by regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and similar agencies in other countries.

Environmental Laws

The company is conscious of its environmental impact and complies with environmental laws and regulations, such as the Water (Prevention and Control of Pollution) Act and the Environment Protection Act in India. Compliance with these laws involves managing waste disposal, emissions, and resource consumption responsibly.

History

NATCO Pharma Limited was founded in 1981. The company was incorporated in 1981.

NATCO Pharma Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** approx. 70% **Agricultural Science Sales:** approx. 30% **TOP 3 Markets:** 1. **India:** approx. 50% 2. **USA:** approx. 30% 3. **Canada:** approx. 10% NATCO Pharma Limited generates the majority of its sales from the pharmaceutical industry, especially through...

At which locations are the company’s products manufactured?

**Production Sites:** - Hyderabad, India - Chennai, India - Mekaguda, India NATCO Pharma Limited has its main production facilities in India, particularly in Hyderabad, Chennai, and Mekaguda. These locations are strategically chosen to efficiently serve both the domestic and international markets....

What strategy does NATCO Pharma pursue for future growth?

**Focus on R&D Investments:** 8% of revenue (2025) **Expansion into International Markets:** 15 new markets (by 2026) **Diversification of Product Portfolio:** Introduction of 10 new products (2024-2026) NATCO Pharma Limited pursues a strategy that heavily emphasizes research and development...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), excipients **Countries of origin:** China, India, USA, Europe NATCO Pharma Limited mainly imports active pharmaceutical ingredients (APIs) and excipients needed for the production of their medications. A large portion of these raw m...

How strong is the company’s competitive advantage?

**Market share in the generic sector:** 5% (estimated, 2026) **R&D investments:** 8% of revenue (2025) **Patents and licenses:** Over 50 active patents (2026) NATCO Pharma Limited has established itself as a significant player in the generics and specialty pharmaceuticals sector. The compan...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 23.5% (estimated for 2026) **Insider Buys/Sells:** No significant transactions reported in 2026 The institutional investor share in NATCO Pharma Limited is approximately 23.5%. This indicates a moderate interest from institutional investors, suggesting confidence...

What percentage market share does NATCO Pharma have?

**Market share of NATCO Pharma Limited:** Estimated at around 3-5% in the Indian pharmaceutical market (2026) **Top competitors and their market shares:** 1. **Sun Pharmaceutical Industries Ltd.:** around 8-10% 2. **Cipla Ltd.:** around 6-8% 3. **Dr. Reddy's Laboratories Ltd.:** around 5-7% 4....

Is NATCO Pharma stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) **Research and Development Ratio:** 7% of revenue (2025) NATCO Pharma Limited has shown solid revenue and profit growth in recent years, indicating a successful product pipeline and a strong market position in the pharmaceutical indust...

Does NATCO Pharma pay a dividend – and how reliable is the payout?

**Dividend Yield:** 2.5% (estimated for 2026) **Dividend History:** Regular payouts in recent years NATCO Pharma Limited has regularly distributed dividends in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2026 is around 2.5%, based on the latest availabl...

New support ticket

Explore

NATCO Pharma Stock Value

NATCO Pharma Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does NATCO Pharma do?

NATCO Pharma Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

NATCO Pharma Stock Value

NATCO Pharma Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does NATCO Pharma do?

NATCO Pharma Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.